Table_1_Clinical Significance of Shared T Cell Epitope Analysis in Early De Novo Donor-Specific Anti-HLA Antibody Production After Kidney Transplantation and Comparison With Shared B cell Epitope Analysis.xlsx
In pre-sensitizing events, immunological memory is mainly created via indirect allorecognition where CD4+ T cells recognize foreign peptides in the context of self-HLA class II (pHLA) presented on antigen-presenting cells. This recognition makes it possible for naive CD4+ T-helper cells to differentiate into memory cells, resulting in the creation of further antibody memory. These responses contribute to effective secretion of donor-specific anti-HLA antibodies (DSA) after second encounters with the same peptide. Preformed donor-reactive CD4+ memory T cells may induce early immune responses after transplantation; however, the tools to evaluate them are limited. This study evaluated shared T cell epitopes (TEs) between the pre-sensitizing and donor HLA using an in silico assay, an alternative to estimate donor-reactive CD4+ memory T cells before transplantation. In 578 living donor kidney transplants without preformed DSA, 69 patients had anti-HLA antibodies before transplantation. Of them, 40 had shared TEs and were estimated to have donor-reactive CD4+ memory T cells. De novo DSA formation in the early phase was significantly higher in the shared TE-positive group than in the anti-HLA antibody- and shared TE-negative groups (p=0.001 and p=0.02, respectively). In conclusion, evaluation of shared TEs for estimating preformed donor-reactive CD4+ memory T cells may help predict the risk of early de novo DSA formation after kidney transplantation.
History
References
- https://doi.org//10.1016/j.chom.2011.04.006
- https://doi.org//10.6002/ect.2016.0292
- https://doi.org//10.1016/s0966-3274(02)00055-2
- https://doi.org//10.1155/2017/2680160
- https://doi.org//10.1002/eji.200939531
- https://doi.org//10.1038/ni.1900
- https://doi.org//10.4049/jimmunol.164.5.2338
- https://doi.org//10.1016/j.coi.2006.02.005
- https://doi.org//10.1097/TP.0000000000003169
- https://doi.org//10.1093/nar/gkz950
- https://doi.org//10.1016/s0198-8859(02)00382-8
- https://doi.org//10.1016/j.transproceed.2013.10.058
- https://doi.org//10.1093/oxfordjournals.bmb.a071501
- https://doi.org//10.1034/j.1399-0012.17.s9.2.x
- https://doi.org//10.1016/j.trim.2008.10.009
- https://doi.org//10.1681/ASN.2015080848
- https://doi.org//10.1034/j.1600-6143.2002.20908.x
- https://doi.org//10.1016/j.trim.2006.09.026
- https://doi.org//10.1097/01.TP.0000112937.12491.42
- https://doi.org//10.1016/j.humimm.2012.12.004
- https://doi.org//10.1111/tan.13881
- https://doi.org//10.1111/j.1399-0039.1994.tb02375.x
- https://doi.org//10.1111/tan.12536
- https://doi.org//10.1097/00007890-196811000-00006
- https://doi.org//10.1093/ndt/gfl202
- https://doi.org//10.1097/TP.0b013e31825ace2c
- https://doi.org//10.1111/ajt.14393
- https://doi.org//10.3389/fimmu.2018.00321
- https://doi.org//10.1111/j.1600-6143.2011.03926.x
- https://doi.org//10.1111/ajt.12590
- https://doi.org//10.1111/ajt.14107
- https://doi.org//10.1111/ajt.14625
- https://doi.org//10.1681/ASN.2014080837
- https://doi.org//10.1016/j.humimm.2017.07.011
- https://doi.org//10.1111/ajt.14247
- https://doi.org//10.1007/s00251-017-0989-3
- https://doi.org//10.1111/cei.12127
- https://doi.org//10.1097/TP.0000000000000821
- https://doi.org//10.1111/ajt.16070
- https://doi.org//10.1111/ajt.13401
- https://doi.org//10.1681/ASN.2007050539
- https://doi.org//10.1371/journal.pone.0200696
- https://doi.org//10.3389/fimmu.2018.02548
Usage metrics
Read the peer-reviewed publication
Categories
- Transplantation Immunology
- Tumour Immunology
- Immunology not elsewhere classified
- Immunology
- Veterinary Immunology
- Animal Immunology
- Genetic Immunology
- Applied Immunology (incl. Antibody Engineering, Xenotransplantation and T-cell Therapies)
- Autoimmunity
- Cellular Immunology
- Humoural Immunology and Immunochemistry
- Immunogenetics (incl. Genetic Immunology)
- Innate Immunity